Abrdn Healthcare Investors

Abrdn Healthcare Investors

HQH·NYSE

$18.99

-0.89%
Financial ServicesAsset Management

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.

At a Glance

Live Snapshot
Market Cap$1.09B
EPS1.8400
P/E Ratio10.32
Earnings Date

hqh

Revenue

Last Annual Value

99.81M

3-Year CAGR

113%

5-Year CAGR

73%

10-Year CAGR

35%

Abrdn Healthcare Investors

Abrdn Healthcare Investors Competitors Analysis of Revenue

HQH · NYSE
CompanyRevenue
CAGR 3Y
CAGR 5Y
CAGR 10Y
99.81M
113.3%72.8%35.5% 
PX logo
P10, Inc.
NYSE:PX
33.99B
420.0%195.6%12.4%
232.25M
9.9%5.8%N/A
171.52M
28.8%15.5%16.4%
235.82M
21.2%52.3%N/A
40.91M
28.9%-2.0%N/A
370.24M
2.7%6.7%12.6%
197.79M
4.6%-0.1%6.9%
239.19M
3.1%6.4%75.4%
830.59M
-0.4%-3.1%9.9%
274.39M
5.0%12.6%31.7%
Abrdn Healthcare Investors

Abrdn Healthcare Investors Fair Value Envelope

HQH · NYSE

Our analysis suggests that HQH has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $18.99, this represents a potential HIDDEN relative to our calculated worth for Abrdn Healthcare Investors.

Intrinsic Value
Current Price: $18.99